Merck Escapes Some Injury Claims In Fosamax MDL

Law360, Los Angeles (March 26, 2014, 7:06 PM EDT) -- A New Jersey federal judge on Wednesday tossed some claims brought against Merck & Co. Inc. in multidistrict litigation accusing the company of negligence over femur fractures and similar injuries allegedly caused by its osteoporosis drug Fosamax, saying those claims are preempted.

Last June, in a related case known as Glynn v. Merck, U.S. District Judge Joel A. Pisano said that claims that Merck had failed to warn a consumer of the possible risk of femur fractures from the use Fosamax were preempted under federal law...
To view the full article, register now.




Case Information

Case Title

MOLNAR et al v. MERCK & CO., INC.

Case Number



New Jersey

Nature of Suit

Personal Inj. Prod. Liability


Freda L. Wolfson

Date Filed

January 2, 2008

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.